Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Renal Cell × Panitumumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 35 Colonic Neoplasms 13 Rectal Neoplasms 12 Neoplasm Metastasis 11 Neoplasms 10 Head and Neck Neoplasms 6 Esophageal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Carcinoma, Squamous Cell 4 Breast Neoplasms 4 Recurrence 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Adenocarcinoma Of Esophagus 3 Triple Negative Breast Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Solid Tumors 1 Ovarian Neoplasms 1 Inflammatory Breast Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Exanthema 1 Cone Dystrophy 3 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1

Interventions

Sunitinib 56 Nivolumab 37 Everolimus 29 Bevacizumab 29 pembrolizumab 24 Sorafenib 23 pazopanib 22 Axitinib 21 aldesleukin 13 Ipilimumab 13 cabozantinib 12 temsirolimus 11 Interferon alpha-2 10 Cyclophosphamide 10 Interleukin-2 9 Radiosurgery 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Immunoglobulin G 7 Erlotinib Hydrochloride 7 Disulfides 6 lenvatinib 5 fludarabine phosphate 5 avelumab 5 Radiotherapy 5 Fluorodeoxyglucose F18 5 peginterferon alfa-2b 4 atezolizumab 4 Nephrectomy 4 Interferon-alpha 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡